Explore more publications!

Harrisburg Wellness Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Harrisburg Wellness Reporter.

Press releases published on May 4, 2026

Pasithea Therapeutics Announces Appointment of Kartik Krishnan, M.D., Ph.D. as Chief Medical Officer
Ardena Strengthens Executive Team to Drive its Next Phase of Growth
Indivior Announces $175 Million Accelerated Share Repurchase
BioCryst Announces European Licensing Agreement with Irish Affiliate of Neopharmed Gentili for Navenibart in Hereditary Angioedema
Tenax Therapeutics Appoints Timothy Healey, MBA as Chief Commercial Officer
NetraMark Appoints Dr. Panteli Theocharous As Fractional Chief Medical Officer, Strengthening Clinical Leadership To Accelerate Global Adoption of NetraAI
Krystal Biotech Announces First Quarter 2026 Financial and Operating Results
10 Barrel Brewing Launches Clean Slate and Salty Sips, Expanding RTD Line with Functional N/A and Low-Sugar Cocktails
Seres Therapeutics Presents Preclinical Data at Digestive Disease Week (DDW) 2026 Supporting SER-603, a Next-Generation Cultivated Live Biotherapeutic Candidate, for Inflammatory Bowel Disease
Centrum Launches Newly Reformulated Adults 50+ Complete Multivitamin with Clinically Shown Cognitive Benefits
Centrum lance sa multivitamine complète Adultes 50+ nouvellement reformulée avec des bienfaits cognitifs démontrés cliniquement
Genyro Announces New Paper Demonstrating How Sidewinder Technology Democratizes DNA Construction at Scale and Facilitates AI-Driven Protein Design
Seer Announces Appointment of Anthony Bazarko as Chief Commercial Officer
Istios Health Partners with CARE-ID to Expand National Infectious Disease Clinical Research Network
ADMA Biologics Announces FDA Approval to Expand the Label for ASCENIV™ to Include Pediatric Immune Compromised Patients Two Years of Age and Older
Axsome Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
Cabaletta Bio Announces Pricing of $150 Million Underwritten Offering
Aura Biosciences Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
Aura Biosciences Announces CEO Transition as Company Advances Phase 3 CoMpass Trial Toward Enrollment Completion
Holland Bloorview Kids Rehabilitation Hospital receives $475,000 commitment from TD Bank Group to support youth with disabilities

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions